These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1751031)

  • 1. (-)-Deprenyl can induce soluble superoxide dismutase in rat striata.
    Clow A; Hussain T; Glover V; Sandler M; Dexter DT; Walker M
    J Neural Transm Gen Sect; 1991; 86(1):77-80. PubMed ID: 1751031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pergolide can induce soluble superoxide dismutase in rat striata.
    Clow A; Hussain T; Glover V; Sandler M; Walker M; Dexter D
    J Neural Transm Gen Sect; 1992; 90(1):27-31. PubMed ID: 1466876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dopaminergic drugs on superoxide dismutase: implications for senescence.
    Glover V; Clow A; Sandler M
    J Neural Transm Suppl; 1993; 40():37-45. PubMed ID: 8294899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats.
    Carrillo MC; Kanai S; Nokubo M; Kitani K
    Life Sci; 1991; 48(6):517-21. PubMed ID: 1899460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology of selegiline ((-)deprenyl). New aspects.
    Knoll J
    Acta Neurol Scand Suppl; 1989; 126():83-91. PubMed ID: 2515725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male mice.
    Carrillo MC; Kitani K; Kanai S; Sato Y; Miyasaka K; Ivy GO
    Life Sci; 1994; 54(14):975-81. PubMed ID: 8139387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of L-deprenyl, D-deprenyl and MDL72974 on mitochondrial respiration: a possible mechanism leading to an adaptive increase in superoxide dismutase activity.
    Thiffault C; Quirion R; Poirier J
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):127-36. PubMed ID: 9387872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ability of (-)deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective.
    Carrillo MC; Kitani K; Kanai S; Sato Y; Ivy GO
    Life Sci; 1992; 50(25):1985-92. PubMed ID: 1593926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short- and long-term (--)-deprenyl administration on mRNA for copper, zinc- and manganese-superoxide dismutase and glutathione peroxidase in rat brain.
    Kunikowska G; Gallagher I; Glover V; Clow A; Jenner P
    Brain Res; 2002 Oct; 953(1-2):1-11. PubMed ID: 12384232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)Deprenyl increases activities of superoxide dismutase (SOD) in striatum of dog brain.
    Carrillo MC; Ivy GO; Milgram NW; Head E; Wu P; Kitani K
    Life Sci; 1994; 54(20):1483-9. PubMed ID: 8190023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in male rats.
    Carrillo MC; Kanai S; Sato Y; Ivy GO; Kitani K
    Biochem Pharmacol; 1992 Dec; 44(11):2185-9. PubMed ID: 1472083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
    Knoll J
    J Neural Transm Suppl; 1987; 25():45-66. PubMed ID: 2828537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum.
    Vizuete ML; Steffen V; Ayala A; Cano J; Machado A
    Neurosci Lett; 1993 Apr; 152(1-2):113-6. PubMed ID: 8515861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy.
    Kitani K; Minami C; Yamamoto T; Maruyama W; Kanai S; Ivy GO; Carrillo MC
    Ann N Y Acad Sci; 2001 Apr; 928():248-60. PubMed ID: 11795516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: the sex and age-related differences in the optimal dose in the rat.
    Carrillo MC; Kanai S; Nokubo M; Ivy GO; Sato Y; Kitani K
    Exp Neurol; 1992 Jun; 116(3):286-94. PubMed ID: 1587332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is brain superoxide dismutase activity increased following chronic treatment with 1-deprenyl?
    Lai CT; Zuo DM; Yu PH
    J Neural Transm Suppl; 1994; 41():221-9. PubMed ID: 7931229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases.
    Knoll J
    J Neural Transm Suppl; 1993; 40():69-91. PubMed ID: 8294902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of soluble superoxide dismutase in rat striata, based on the inhibition of nitrite formation from hydroxylammonium chloride.
    Pattichis K; Louca LL; Glover V
    Anal Biochem; 1994 Sep; 221(2):428-31. PubMed ID: 7810893
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of pergolide and MDL 72974 on rat brain CuZn superoxide dismutase.
    Clow A; Freestone C; Lewis E; Dexter D; Sandler M; Glover V
    Neurosci Lett; 1993 Dec; 164(1-2):41-3. PubMed ID: 8152612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.